Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Riley

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Immunological Reviews|May 12, 2009
PD-1 signaling in primary T cellsJames L Riley
The New England Journal of Medicine|June 4, 2013
Combination checkpoint blockade--taking melanoma immunotherapy to the next levelJames L Riley
Molecular Therapy. Advances|May 15, 2026
CD19 CAR T cell therapy in systemic sclerosis: A case study that reaffirms the promise of cell therapy to treat autoimmune diseaseJames L Riley
Cell Metabolism|August 9, 2018
Translating In Vitro T Cell Metabolic Findings to In Vivo Tumor Models of Nutrient CompetitionChristopher Ecker, James L Riley
Cell Research|May 5, 2021
Ultrasensitive antigen density discrimination by synNotchDivanshu Shukla, James L Riley
Blood|September 9, 2004
The CD28 family: a T-cell rheostat for therapeutic control of T-cell activationJames L Riley, Carl H June
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 22, 2015
Engineering T Cells to Functionally Cure HIV-1 InfectionRachel S Leibman, James L Riley
Trends in Immunology|December 26, 2006
The road to recovery: translating PD-1 biology into clinical benefitJames L Riley, Carl H June
The Journal of Infectious Diseases|May 19, 2017
Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus ReservoirJames L Riley, Luis J Montaner
Nature Cancer|February 5, 2022
How to kill T<sub>reg</sub> cells for immunotherapyGavin I Ellis, James L Riley
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Immunological Reviews|May 12, 2009
PD-1 signaling in primary T cellsJames L Riley
The New England Journal of Medicine|June 4, 2013
Combination checkpoint blockade--taking melanoma immunotherapy to the next levelJames L Riley
Molecular Therapy. Advances|May 15, 2026
CD19 CAR T cell therapy in systemic sclerosis: A case study that reaffirms the promise of cell therapy to treat autoimmune diseaseJames L Riley
Cell Metabolism|August 9, 2018
Translating In Vitro T Cell Metabolic Findings to In Vivo Tumor Models of Nutrient CompetitionChristopher Ecker, James L Riley
Cell Research|May 5, 2021
Ultrasensitive antigen density discrimination by synNotchDivanshu Shukla, James L Riley
Blood|September 9, 2004
The CD28 family: a T-cell rheostat for therapeutic control of T-cell activationJames L Riley, Carl H June
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 22, 2015
Engineering T Cells to Functionally Cure HIV-1 InfectionRachel S Leibman, James L Riley
Trends in Immunology|December 26, 2006
The road to recovery: translating PD-1 biology into clinical benefitJames L Riley, Carl H June
The Journal of Infectious Diseases|May 19, 2017
Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus ReservoirJames L Riley, Luis J Montaner
Nature Cancer|February 5, 2022
How to kill T<sub>reg</sub> cells for immunotherapyGavin I Ellis, James L Riley
Pageof 13